Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes

Circulation

Volumn 97, Issue 2, 1998, Pages 194-203

  Leri, Annarosa ^b   Liu, Yu ^b   Malhotra, Ashwani ^b   Li, Qiong ^b   Stiegler, Peter ^b   Claudio, Pier Paolo ^b   Giordano, Antonio ^b   Kajstura, Jan ^b   Hintze, Thomas H ^b   Anversa, Piero ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Apoptosis; Heart failure; Molecular biology; Pacing

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOG; GENE EXPRESSION REGULATION; HEART FAILURE; HEART PACING; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

EID: 0031893042     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.2.194     Document Type: Article

References (63)

1. Colucci WS. Apoptosis in the heart. N Engl J Med. 1996;335:1224-1226.
2. Armstrong PW, Stopps TP, Fold SE, DeBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies ot heart failure. Circulation. 1986;74:1075-1084.
3. Shannon RP, Komamura K, Stambler BS, Bigaud M, Wanders WT, Vatner SF. Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol. 1991;260:H1903-H1911.
4. Zellner JL, Spinale FG, Eble DM, Hewett KW, Crawford FA. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res. 1991;69:590-600.
5. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P. The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995;27:291-305.
6. Komamura K, Shannon RP, Pasipoufarides A, Ihara T, Lader AS, Patrick TA, Bishop SP, Vatner SF. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure. J Clin Invest. 1992;89:1825-1838.
7. Komamura K, Shannon RP, Ihara T, Shen YT, Mirsky I, Bishop SP, Vatner SF. Exhaustion of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol. 1993;265:H1119-H1131.
8. Spinale FG, Zellner JL, Tomita M, Ctawford FA, Ziles MR. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res. 1991;69:1058-1067.
9. Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P. The cellular basis of pacing-induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 1995;92:2306-2317.
10. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest. 1995;73:771-787.
11. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest. 1994;71:219-225.
12. Mundle SD, Raza A. The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest. 1995;72:611-612.
13. Didenko VV, Hornsby PJ. Presence of double-stranded breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
14. Hintze TH, Wang J, Seyedi N, Wohn MS. Role of EDRF/NO in chronic high coronary blood flow states during myocardial dysfunction and failure. In: Bevan JR, Kaley G, Rubanyi GM, eds. Flow Dependent Regulation of Vascular Function. New York, NY: Oxford University Press; 1995:320-339.
15. Stadler JB, Billiar TK, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol. 1991;260:C910-C916.
16. Geng YJ, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res. 1992;71:1268-1276.
17. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 1994;75:1086-1095.
18. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993;75:241-251.
19. Johnson TM, Yu Z-X, Ferrans VJ, Lowenstein RA, Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A. 1996;93:11848-11852.
20. Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci U S A. 1995;92:4507-4511.
21. RAS in Ras-induced apoptosis. J Biol Chem. 1996;271:2376-2379.
22. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem. 1997;272:11671-11673.
23. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell. 1193;74:609-619.
24. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293-299.
25. Miyashita T, Krajewski S, Krajewski M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator ot bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994;9:1799-1805.
26. 2ft. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131-1141.
27. Mathew R, Wang J, Gewitz MH, Hintze TH, Wolin MS. Congestive heart failure alters receptor-dependent cAMP-mediated relaxation of canine pulmonary arteries. Circulation. 1993;87:1722-1728.
28. Wang J. Seyedi N, Xu XB, Wolin MS, Hintze TH, Defective endothelium-mediated control ot coronary circulation in conscious dogs after heart failure. Am J Physiol. 1994;266:H670-H680.
29. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, Gambert SR, Cigola E, Anversa P. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 1996;28:2005-2016.
30. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
31. + conformation of wild type p53 binds DNA. Oncogem. 1996;13:1297-1303.
32. Hecker D, Page G, Lohram M, Weiland S, Scheidtmann KH. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene. 1996;12:953-961.
33. Arrends MJ, Morris RG, Wyllie AH. Apoptosis: the role of endonuclease. Am J Pathol. 1990;136:593-608.
34. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523-526.
35. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74:957-967.
36. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993;362:847-849.
37. Ryan JJ, Prochownik E, Gottlieb CA, Apel IJ, Merino R, Nunez G, Clarke MF. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A. 1994;91:5878-5882.
38. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ. A p53-dependent mouse spindle checkpoint. Science. 1995;267:1353-1356.
39. Chemova OB, Chernov MV, Agarwal ML, Taylor WR, Stark GR. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem Sci. 1995;20:431-434.
40. Hansen RS, Braithwaite AW. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras. Oncogene. 1996;13:995-1007.
41. El-Deiry WA, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993;75:817-825.
42. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 1994;266:1376-1379.
43. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 1994;54:3131-3135.
44. Hupp TR, Lane DP. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harb Symp Quant Biol. 1994;59:195-206.
45. Meggs LG, Tillotson J, Huang H, Sonnenblick EH, Capasso JM, Anversa P. Noncoordinate regulation of & alpha;-1 adrenoreceptor coupling and reexpression of & alpha; skeletal actin in myocardial infarction-induced left ventricular failure in rats. J Clin Invest. 1990;86:1451-1458.
46. Zhang X, Dostal DE, Reiss K, Cheng W, Kajstura J, Li P, Huang H, Sonnenblick EH, Meggs LG, Baker KM, Anversa P. Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. Am J Physiol. 1995;269:H1791-H1802.
47. Pierzchalski P, Reiss K, Cheng W, Cirielli C, Kajstura J, Nitahara JA, Rizk M, Capogrossi MC, Anversa P. p53 induces myocyte apoptosis via the activation of the renin-angiotensin system. Exp Cell Res. 1997;234:57-65.
48. Wang H-G, Rapp UR, Reed JC. Bcl-2 targets the protein kinases Raf-2 to mitochondria. Cell. 1996;87:629-638.
49. 2+. Oncogene. 1996;12:2259-2266.
50. Shimizu S, Eguchi Y, Kamiike W, Matsuda H, Yoshihide T. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene. 1996;12:2251-2257.
51. Krajewski S, Tanaka S, Takayama S, Shibler M, Fenton W, Reed J. Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence ul the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrane. Cancer Res. 1993;53:4701-4714.
52. Zamzami N, Susin A, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med. 1996;183:1533-1544.
53. 1 an inhibitor of programmed cell death. Nature. 1996;381:335-341.
54. Oltvai ZN, Korsmeyer SJ. Checkpoints of dueling dimers foil death wishes. Cell. 1994;79:189-192.
55. Farrow SN, Brown R. New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev. 1996;6:45-49.
56. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67:871-885.
57. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560-1568.
58. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 1996;148:141-149.
59. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara JA, Chapnick S, Reiss K, Olivetti G, Anversa P. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol. 1996;217: H1215-H1228.
60. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Jajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
61. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
62. Bursch W, Oberhammer F, Schuhe-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci. 1992;13:245-251.
63. Oberhammer F, Wilson JM, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M, Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 1993;12:3679-3684.